Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis
2010-024561-43Phase 2Completed
- Sponsor
- Danish Multiple Sclerosis Center
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methylprednisolone in multiple sclerosis (MS), sponsored by Danish Multiple Sclerosis Center. Primary endpoint: Change in cerebrospinal fluid osteopontin concentration. Started Feb 2011; status: completed.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2010-024561-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024561-43.